Inventor · disambiguated record
Daniel H. Fowler
Also filed as: FOWLER DANIEL · FOWLER DANIEL H · FOWLER DANIEL HARDING
8 granted patents·20 pending applications·133 citations·filing 1995–2025
83Inventor score
Files withRAPA THERAPEUTICS LLC6GAMMADELTA THERAPEUTICS LTD4MEDICAL COLLEGE WISCONSIN INC3MEDIN JEFFREY A3UNIV PENNSYLVANIA3
Top patents by PatentIndex Score
28 records- 0190US5643786AMethod for isolating dendritic cellsUS HEALTH·Filed 1995·Granted Jul 1, 1997·123 cites·7 claims
- 0284US10808225B2Use of PDL1 expressing cells to convert T cells into regulatory T cellsUNIV PENNSYLVANIA·Filed 2017·Granted Oct 20, 2020·2 cites·17 claims
- 0378US9644179B2Use of PDL1 expressing cells to convert T cells into regulatory T cellsUNIV PENNSYLVANIA·Filed 2012·Granted May 9, 2017·4 cites·6 claims
- 0476US7718196B2Rapamycin-resistant T cells and therapeutic uses thereofUS GOV HEALTH & HUMAN SERV·Filed 2005·Granted May 18, 2010·3 cites·17 claims
- 0568US8075921B2Rapamycin-resistant T cells and therapeutic uses thereofFOWLER DANIEL H·Filed 2010·Granted Dec 13, 2011·1 cites·7 claims
- 0668US2025114358A1Als treatment using induced regulatory t (itreg) cellsRAPA THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0767US2024082308A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 0864US2025195652A1Method for Engineering Innate-Like LymphocytesUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 0963US2025352570A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1062US2021277356A1Use of pdl1 expressing cells to convert t cells into regulatory t cellsUNIV PENNSYLVANIA·Filed 2020·Application pending·0 cites
- 1161US12239693B2Use of lentivector-transduced T-Rapa cells for amelioration of lysosomal storage disordersMEDICAL COLLEGE WISCONSIN INC·Filed 2019·Granted Mar 4, 2025·0 cites·12 claims
- 1261US12076344B2T-Rapa cells as novel effector cell type for chimeric antigen receptor therapyMEDICAL COLLEGE WISCONSIN INC·Filed 2019·Granted Sep 3, 2024·0 cites·19 claims
- 1360US12239647B2ALS treatment using induced regulatory T (iTREG) cellsRAPA THERAPEUTICS LLC·Filed 2021·Granted Mar 4, 2025·0 cites·17 claims
- 1457US2021290674A1Methods for treating myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1555US2023190780A1Methods for immunotherapyPREC BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 1654US2023270781A1Treatment or prevention of pro-inflammatory diseases or conditions using induced regulatory t (itreg) cellsRAPA THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1754US2025170221A1Use of lentivector-transduced t-rapa cells for amelioration of lysosomal storage disordersMEDICAL COLLEGE WISCONSIN INC·Filed 2025·Application pending·0 cites
- 1854US2023159893A1Antigen presenting t cells, sensitized, manufactured t cells and methods of treatment using the sameRAPA THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1950US2021268029A1Methods for treating cancer with manufactured t cellsRAPA THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2049US2009074733A1Thymidylate kinase mutants and uses thereofMEDIN JEFFREY A·Filed 2006·Application pending·0 cites
- 2148US2011014165A1Thymidylate Kinase Mutants and Uses ThereofMEDIN JEFFREY A·Filed 2010·Application pending·0 cites
- 2248US2009068158A1Thymidylate kinase mutants and uses thereofMEDIN JEFFREY A·Filed 2008·Application pending·0 cites
- 2347US2021270843A1Immune Monitoring of Neuro-Inflammatory Amyotrophic Lateral Sclerosis (ALS)RAPA THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2445US2004241153A1Methods of generating human cd4+ th1 cellsFiled 2002·Application pending·0 cites
- 2545US2004175827A1Methods of generating human cd4+ th2 cells and uses thereofFiled 2002·Application pending·0 cites
- 2643US2004258661A1Generation of use of tc1 and tc2 cellsFiled 2002·Application pending·0 cites
- 2740US2023149459A1V delta1+ t cells for the treatment of myeloid malignanciesGAMMADELTA THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2833US2012251514A1Modulated programmed death ligand-1FOWLER DANIEL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel H. Fowler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →